Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ELRIG Announces Drug Discovery 2012 Keynotes and Workshops

Published: Tuesday, August 14, 2012
Last Updated: Tuesday, August 14, 2012
Bookmark and Share
European Laboratory Robotics Interest Group have announced details of the keynote speakers and workshop programme for its 6th Annual Drug Discovery Conference.

ELRIG is also calling for abstract submissions (posters@elrig.org) for the main poster sessions and for the SLAS Young Scientist Award, the winner of which will be awarded with an expenses paid trip to present and participate in the Student Poster Competition at SLAS2013, 12th-16th January 2013 in Florida.

Keynote presentations will be given by Dr Steve Rees, Vice-President of Screening Sciences and Sample Management at AstraZeneca, and Section President of SLAS (‘Collaborative Models for Lead Discovery’), and Dr Chris Moxham, Associate Vice President at ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company (‘Eli Lilly and Co.'s Open Innovation Drug Discovery Initiative’). The keynote speakers will also close the meeting with a debate on ‘The Evolving Landscape for Drug Discovery’.

A number of vendor workshop sessions will be held during the event, as well as lunchtime ‘Informatics: Making Knowledge from Laboratory Data’ Seminars on both days of the event. The lunchtime Informatics Seminars are: ‘How best to enable externalisation of drug discovery’ and ‘Knowledge at your finger tips’.
Workshop sessions include: ‘Deeper insights – better prediction of drug safety and efficacy’ from GE Healthcare Drug Discovery Suite; and ‘Early drug de-risking with 3D-cell-culture systems’ with InSphero.

Drug Discovery 2012 is to be held on 5th – 6th September 2012 at the Manchester Central Convention Complex, and features over 100 exhibitor booths, an Innovation Zone, Media Area, Careers Zone and Dragons Den. Registration for the event is free and over 1,000 delegates are expected to attend.

To find out more and to register for the conference please visit www.ELRIG.org


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ELRIG Announces Speaker Programme for Drug Discovery 2012 Conference
The 6th Annual Drug Discovery Conference, in collaboration with SLAS, will be held at Manchester Central Convention Complex on 5th – 6th September 2012.
Monday, April 30, 2012
ELRIG Drug Discovery 2011
The 5th ELRIG Drug Discovery show, held in Manchester on 7 & 8th September 2011, attracted 1,125 delegates and a record number of exhibitors.
Thursday, September 22, 2011
ELRIG Drug Discovery 2010 - Free Online Registration – Book you place Now
ELRIG, the European Laboratory Robotics Interest Group, are proud to announce that FREE registration to Drug Discovery 2010 is open online. Drug Discovery 2010 will be held at the Ricoh Arena, Coventry, UK on 1st and 2nd September 2010.
Monday, August 02, 2010
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!